Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Real-World Treatment Experience of Venetoclax in Combination with Hypomethylating Agents in Patients with Newly Diagnosed Acute Myeloid Leukemia: Updated Experience from a Predominately Community Setting in the US

Pankit Vachhani, Esprit Ma, Tao Xu, Melissa Montez, Sarah Worth, Wei-Han Cheng, Michael Werner, Jonathan Abbas, William Donnellan

Blood (2022) 140 (Supplement 1): 683–684.

https://doi.org/10.1182/blood-2022-157509

Published: 2022

Journal Articles

Clinical Profile and Long-Term Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab in a Real-World Setting: High Frequency of Anemia Despite Decreased Intravascular Hemolysis

Katharina Versmold, Ferras Alashkar, Carina Raiser, Richard Ofori-Asenso, Tao Xu, Yutong Liu, Pablo Katz, Aijing Shang, Alexander Roeth

Blood (2021) 138 (Supplement 1): 4314.

https://doi.org/10.1182/blood-2021-147162

Published: 2021

Journal Articles

Lab-Based Response Assessment Algorithm Recapitulates Investigator's Response Assessment in the Phase 3 Bellini Trial

Stefka Tyanova, Tao Xu, Mellissa Williamson, Alberto Rocci, Wan-Jen Hong, Huan Jin, Sudeep Karve, James Roose, Ahmed Sawas, Shaji Kumar

Blood (2021) 138 (Supplement 1): 4758.

https://doi.org/10.1182/blood-2021-147713

Published: 2021

Journal Articles

A Novel Methodology for Building Longitudinal, Patient-Centric Real World Datasets in Hemophilia A

Mark W Skinner, Gillian Hanson, Tao Xu, Richard Ofori-Asenso, Richard H. Ko, Emily Cibelli, Francis Nissen, Michelle Witkop, Fabian Sanabria, Amy D. Shapiro

Blood (2021) 138 (Supplement 1): 594.

https://doi.org/10.1182/blood-2021-146160

Published: 2021

Journal Articles

Assessment of Associations between Derived Response and Overall Survival in Patients with Multiple Myeloma Using a US-Based Electronic Health Records Database

Tao Xu, Stefka Tyanova, Mellissa Williamson, Alberto Rocci, Kasra Yousefi, Shaji Kumar

Blood (2021) 138 (Supplement 1): 3770.

https://doi.org/10.1182/blood-2021-150148

Published: 2021

Journal Articles

Characterizing Mild and Moderate Hemophilia A Patients in the Real World: A Patient-Centric Approach

Michelle Witkop, Tao Xu, Gillian Hanson, Richard Ofori-Asenso, Richard H. Ko, Emily Cibelli, Martynas Aizenas, Mark W Skinner, Fabian Sanabria, Amy D. Shapiro

Blood (2021) 138 (Supplement 1): 2107.

https://doi.org/10.1182/blood-2021-146543

Published: 2021

Journal Articles

Real World Treatment Patterns and Outcomes of Venetoclax (Ven) and Hypomethylating Agents (HMA) in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) in the United States

Pankit Vachhani, Jonathan A. Abbas, Evelyn M. Flahavan, Esprit Ma, Tao Xu, Huan Jin, Melissa Montez, Weize Huang, Anda Gershon, Grace Ku, Brannon Flores, Maika Onishi, Cat N. Bui, William Donnellan

Blood (2021) 138 (Supplement 1): 2290.

https://doi.org/10.1182/blood-2021-147851

Published: 2021

Journal Articles

An Insight into the Impact of Hemophilia a on Daily Life According to Disease Severity: A Preliminary Analysis of the CHESS II Study

Declan Noone, MSc, Francis Nissen, Tao Xu, Tom Burke, Sohaib Asghar, Harpal Dhillon, Martynas Aizenas, Oliver Meier, Jamie O'Hara, MSc, Kate Khair, PhD

Blood (2020) 136 (Supplement 1): 1–3.

https://doi.org/10.1182/blood-2020-136952

Published: 2020

Journal Articles

Treatment Patterns and Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Hypomethylating Agents (HMA) in the United States (US)

Timothy S. Pardee, MDPhD, Jessica Oschwald, Esprit Ma, Tao Xu, Melissa Montez, Giridharan Ramsingh, Wan-Jen Hong, MD, Michelle Choi, Evelyn M. Flahavan

Blood (2020) 136 (Supplement 1): 14–16.

https://doi.org/10.1182/blood-2020-134830

Published: 2020

Journal Articles

Use of Venetoclax (VEN) and Hypomethylating Agents (HMA) in Newly Diagnosed Acute Myeloid Leukemia (AML) in the United States (US) - Real World (RW) Response, Treatment Duration, Dose and Schedule Modifications

William Donnellan, MD, Tao Xu, Esprit Ma, Huan Jin, Melissa Montez, Michelle Choi, Grace Ku, Raj Anand Rajeswaran, Giridharan Ramsingh, Evelyn M. Flahavan

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-134820

Published: 2020

Journal Articles

Treatment Patterns and Outcomes of Multiple Myeloma (MM) with Chromosome Translocation (11;14) in United States (US) Routine Clinical Practice

Shebli Atrash, MD, Evelyn M. Flahavan, Tao Xu, Esprit Ma, Sudeep Karve, Wan-Jen Hong, MD, Gilbert Jirau-Lucca, Michael Nixon, Sikander Ailawadhi

Blood (2020) 136 (Supplement 1): 40–43.

https://doi.org/10.1182/blood-2020-134703

Published: 2020

Journal Articles

Trial in Progress: A Real-World Cohort Study Reporting Patient Profiles, Clinical Outcomes, and Unmet Medical Need of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab in the Essen Center in Germany

Katharina Versmold, Carina Raiser, Imi Faghmous, BS, MSc, MA, MPH, PhD, Pablo Katz, MD, Aijing Shang, MD PhD, Tao Xu, Alexander Röth, MD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-140693

Published: 2020

Journal Articles

The Role of STAT5 in HOXA9-Associated Leukemia

Peilin Ma, MD, PhD, Yuqing Sun, MS, Jingya Wang, PhD, Weihua Song, MD, PhD, Tao Xu, PhD, Reuben Kapur, PhD, Jay L. Hess, MD PhD

Blood (2016) 128 (22): 3919.

https://doi.org/10.1182/blood.V128.22.3919.3919

Published: 2016

Journal Articles

Characterization of the Molecular Interplay Between HOXA9 and Ogt in Leukemia

Jean-Francois M Rual, PhD, Tao Xu, PhD, Cailin Collins, Honglai Zhang, PhD, Jingya Wang, Rork Kuick, MS, Joel Bronstein, Venkatesha Basrur, PhD, Sung Soo Park, PhD, Kim Ha, Lili Chen, Kojo S.J. Elenitoba-Johnson, MD, Andrew G. Muntean, PhD, Jay L. Hess, MD PhD

Blood (2014) 124 (21): 3533.

https://doi.org/10.1182/blood.V124.21.3533.3533

Published: 2014

Journal Articles

The O-Linked N-Acetylglucosamine Transferase Modifies HOXA9 and Inhibits HOXA9-Driven Immortalization

Jean-Francois M Rual, PhD, Jay L. Hess, MD, PhD, MHSA, Tao Xu, PhD, Cailin Collins, Honglai Zhang, PhD, Kimberly Ha, Sung Soo Park, PhD, Joel Bronstein, Jingya Wang

Blood (2013) 122 (21): 4901.

https://doi.org/10.1182/blood.V122.21.4901.4901

Published: 2013

Journal Articles

P-Selectin Activates Leukocyte Integrin alphaMbeta2 by Recruiting Phosphatidylinositol-3 Kinase to P-Selectin Glycoprotein Ligand-1 Cytoplasmic Domain through Adaptor Protein Naf1.

Jian-Guo Geng, MD, Ph.D, Hai-Bo Wang, B.S., Ming Chen, Ph.D., Tao Xu, B.S., Lei Zhang, B.S., Xueliang Zhu, Ph.D., Edward F. Plow, Ph.D.

Blood (2004) 104 (11): 652.

https://doi.org/10.1182/blood.V104.11.652.652

Published: 2004

NARROW

Real-World Treatment Experience of Venetoclax in Combination with Hypomethylating Agents in Patients with Newly Diagnosed Acute Myeloid Leukemia: Updated Experience from a Predominately Community Setting in the US

Clinical Profile and Long-Term Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab in a Real-World Setting: High Frequency of Anemia Despite Decreased Intravascular Hemolysis

Lab-Based Response Assessment Algorithm Recapitulates Investigator's Response Assessment in the Phase 3 Bellini Trial

A Novel Methodology for Building Longitudinal, Patient-Centric Real World Datasets in Hemophilia A

Assessment of Associations between Derived Response and Overall Survival in Patients with Multiple Myeloma Using a US-Based Electronic Health Records Database

Characterizing Mild and Moderate Hemophilia A Patients in the Real World: A Patient-Centric Approach

Real World Treatment Patterns and Outcomes of Venetoclax (Ven) and Hypomethylating Agents (HMA) in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) in the United States

An Insight into the Impact of Hemophilia a on Daily Life According to Disease Severity: A Preliminary Analysis of the CHESS II Study

Treatment Patterns and Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Hypomethylating Agents (HMA) in the United States (US)

Use of Venetoclax (VEN) and Hypomethylating Agents (HMA) in Newly Diagnosed Acute Myeloid Leukemia (AML) in the United States (US) - Real World (RW) Response, Treatment Duration, Dose and Schedule Modifications

Treatment Patterns and Outcomes of Multiple Myeloma (MM) with Chromosome Translocation (11;14) in United States (US) Routine Clinical Practice

Trial in Progress: A Real-World Cohort Study Reporting Patient Profiles, Clinical Outcomes, and Unmet Medical Need of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab in the Essen Center in Germany

The Role of STAT5 in HOXA9-Associated Leukemia

Characterization of the Molecular Interplay Between HOXA9 and Ogt in Leukemia

The O-Linked N-Acetylglucosamine Transferase Modifies HOXA9 and Inhibits HOXA9-Driven Immortalization

P-Selectin Activates Leukocyte Integrin alphaMbeta2 by Recruiting Phosphatidylinositol-3 Kinase to P-Selectin Glycoprotein Ligand-1 Cytoplasmic Domain through Adaptor Protein Naf1.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only